Back to Authors

Pencille, Laurie

Mayo Clinic

Center for Science of HealthCare Delivery, Mayo Clinic, Rochester, MN 55905, USA.

Citations 2

Deploying Clinical Decision Support for Familial Hypercholesterolemia
Bangash, Hana , Sutton, Joseph , Gundelach, Justin H. , Pencille, Laurie J., Makkawy, Ahmed , Elsekaily, Omar, Mir, Ali Mohammadpour, Pencille, Laurie, Mir, Ali, Freimuth, Robert, Dikilitas, Ozan , Freimuth, Robert R. , Caraballo, Pedro J. , Kullo, Iftikhar J.

ACI Open | January 1, 2021 | Volume: 04 | Issue: 02 | Pages: e157-e161

10.1055/s-0040-1721489 Get It

AbstractObjective Familial hypercholesterolemia (FH), a prevalent genomic disorder that increases risk of coronary heart disease, remains significantly underdiagnosed. Clinical decision support (CDS) tools have the potential to increase FH detection. We describe our experience in the development and implementation of a genomic CDS for FH at a large academic medical center.Methods CDS development and implementation were conducted in four phases: (1) development and validation of an algorithm to identify “possible FH”; (2) obtaining approvals from institutional committees to develop the CDS; (3) development of the initial prototype; and (4) use of an implementation science framework to evaluate the CDS.Results The timeline for this work was approximately 4 years; algorithm development and validation occurred from August 2018 to February 2020. During this 4-year period, we engaged with 15 stakeholder groups to build and integrate the CDS, including health care providers who gave feedback at each stage of development. During CDS implementation six main challenges were identified: (1) need for multiple institutional committee approvals; (2) need to align the CDS with institutional knowledge resources; (3) need to adapt the CDS to differing workflows; (4) lack of institutional guidelines for CDS implementation; (5) transition to a new institutional electronic health record (EHR) system; and (6) limitations of the EHR related to genomic medicine.Conclusion We identified multiple challenges in different domains while developing CDS for FH and integrating it with the EHR. The lessons learned herein may be helpful in streamlining the development and deployment of CDS to facilitate genomic medicine implementation.
An Implementation Science Framework to Develop a Clinical Decision Support Tool for Familial Hypercholesterolemia
Bangash, Hana , Pencille, Laurie J., Gundelach, Justin H. , Makkawy, Ahmed , Sutton, Joseph , Makkawy, Lenae, Kopecky, Stephen L. , Caraballo, Pedro J. , Pencille, Laurie, Kopecky, Stephen, Freimuth, Robert, Caraballo, Pedro J , Dikilitas, Ozan , Freimuth, Robert R. , Kullo, Iftikhar J.

Journal of Personalized Medicine | July 23, 2020 | Volume: 10 | Issue: 3 | Pages: 67

10.3390/jpm10030067 Get It

Electronic health record (EHR)-based clinical decision support (CDS) can address the low awareness and undertreatment of familial hypercholesterolemia (FH), a disorder associated with a markedly increased risk of coronary heart disease. We aimed to incorporate provider perspectives into the development and implementation of a CDS tool for FH. An implementation science framework and a user-centered design process were used to create a CDS tool for FH. Primary care physicians and specialist physicians participated in qualitative interviews, usability testing and an implementation survey. The CDS was configured in two formats—a best practice alert (BPA) and an in-basket message and subsequently deployed in the EHR in silent mode. The key themes that emerged from the analysis of interview transcripts included understanding and awareness of FH, clinical workflow, physician preferences and value of CDS tools, perspectives on patient needs and values and dissemination and implementation. Recommendations related to usability included preferred CDS format and placement, content, timing and frequency, and level of alert urgency/prioritization. In response to the survey, 84.6% of physicians agreed that the CDS would improve early FH diagnosis and 92.3% agreed that it would help them identify and manage FH patients. Physician feedback led to iterative CDS refinement. In summary, we developed a CDS tool for FH using an implementation science framework and physician feedback. Initial deployment revealed a significant burden of FH and the potential for the CDS tool to have a large impact.